20160128 EGA Regulatory and Scientific Affairs Conferenc

European health community issues key questions Article 50 negotiations must answer for patients and public health

8 March 2018

The European Health Community has warned that time is running […]

Read more

Supply chain commitment to tackling problem of medicine shortages

2 March 2018


El sistema español podría mejorar su coste-eficiencia con un plan nacional

27 February 2018


IGBA launches a biosimilar medicines information campaign

1 February 2018


IGBA congratulates the Australian government for maintaining their biologics naming convention and for strengthening pharmacovigilance

29 January 2018


2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems

25 January 2018

This week in London, Medicines for Europe gathers regulators and […]

Read more

Vigilance saves lives! More focus needed on sustainability and patient engagement

24 January 2018

National authorities, regulators, industry leaders and key stakeholders gathered in […]

Read more

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

18 January 2018

Geneva, 18 January 2018 – Today, the AMR Industry Alliance […]

Read more

What Challenges Should Biosimilar Companies Expect In 2018?

10 January 2018


2018 Outlook: Biosimilar Trends To Watch

3 January 2018


Subscribe to our newsletter